In particular, meloxicam 7.5 mg/day was associated with a lower incidence ... upper gastrointestinal haemorrhage and peptic ulcer (28.3, 0.4 and 0.3 per 1000 patient-months, respectively) among ...

Meloxicam (sold under the brand name Mobic) is a prescription-only nonsteroidal anti-inflammatory drug (NSAID) for treating ...

Meloxicam is well absorbed after oral administration, with an absolute bioavailability of 89% that is not markedly affected by concomitant intake of food. Meloxicam reaches maximum plasma ...